Conference Proceedings
FACTORS ASSOCIATED WITH ONCOGENIC HUMAN PAPILLOMAVIRUS PREVALENCE AMONG AUSTRALIAN WOMEN FOLLOWING VACCINE INTRODUCTION
Dorothy Machalek, Hannah Shilling, Steph Atchison, Alyssa Cornall, Julia Brotherton, Deborah Bateson, Kathleen Mcnamee, Jane Hocking, John Kaldor, Marcus Chen, Christopher Fairley, Eric Chow, S Rachel Skinner, Gerald Murray, Monica Molano, Sepehr Tabrizi, Suzanne Garland
SEXUALLY TRANSMITTED INFECTIONS | BMJ PUBLISHING GROUP | Published : 2019
Abstract
In Australia, high and widespread uptake of the quadrivalent human papillomavirus (HPV) vaccine has led to substantial population-level reductions in the prevalence of HPV16/18 in women aged ≤35 years. We assessed risk factors for oncogenic HPV detection among 18–35 year old women in 2015–2018. Women attending health services across Australia provided a self-collected (vaginal) or clinician-collected (cervical) specimen for HPV genotyping (Roche Linear Array) and completed a questionnaire. HPV vaccination status was validated against the National HPV Vaccination Program Register. Odds ratios (ORs) and 95% confidence intervals (CI) were calculated for factors associated with detection of any ..
View full abstract